Organon & Co. Diluted Shares Outstanding (Weighted Average)
Organon & Co. (OGN) reported Diluted Shares Outstanding (Weighted Average) of 270.45 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-07-31
- Organon & Co. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 270.45M shares, a 3.96% increase year-over-year.
- Organon & Co. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 262.90M shares, a 0.73% increase year-over-year.
- Organon & Co. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 261.22M shares, a 0.52% increase year-over-year.
- Organon & Co. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 260.65M shares, a 0.34% increase year-over-year.
- Organon & Co. weighted average number of shares outstanding, diluted for fiscal 2025 was 260.76M shares, a 0.62% increase from fiscal 2024.
- Organon & Co. weighted average number of shares outstanding, diluted for fiscal 2024 was 259.15M shares, a 1.12% increase from fiscal 2023.
- Organon & Co. weighted average number of shares outstanding, diluted for fiscal 2023 was 256.27M shares, a 0.43% increase from fiscal 2022.
- Organon & Co. weighted average number of shares outstanding, diluted for fiscal 2022 was 255.17M shares, a 0.38% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 270.45M shares 10-Q · filed 2026-07-31 | 266.68M shares 10-Q · filed 2026-07-31 | 264.86M shares derived: average of 3 quarters · filed 2026-07-31 | 263.81M shares derived: average of 4 quarters · filed 2026-07-31 | |||
| 2026-03-31 | 262.90M shares 10-Q · filed 2026-05-04 | 262.06M shares derived: average of 2 quarters · filed 2026-05-04 | 261.59M shares derived: average of 3 quarters · filed 2026-05-04 | 261.23M shares derived: average of 4 quarters · filed 2026-07-31 | |||
| 2025-12-31 | 261.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 260.94M shares derived: average of 2 quarters · filed 2026-02-24 | 260.68M shares derived: average of 3 quarters · filed 2026-07-31 | 260.76M shares 10-K · filed 2026-02-24 | |||
| 2025-09-30 | 260.65M shares 10-Q · filed 2025-11-10 | 260.40M shares derived: average of 2 quarters · filed 2026-07-31 | 260.61M shares 10-Q · filed 2025-11-10 | 260.42M shares derived: average of 4 quarters · filed 2026-07-31 | |||
| 2025-06-30 | 260.16M shares 10-Q · filed 2026-07-31 | 260.58M shares 10-Q · filed 2026-07-31 | 260.35M shares derived: average of 3 quarters · filed 2026-07-31 | 260.20M shares derived: average of 4 quarters · filed 2026-07-31 | |||
| 2025-03-31 | 261.00M shares 10-Q · filed 2026-05-04 | 260.44M shares derived: average of 2 quarters · filed 2026-05-04 | 260.21M shares derived: average of 3 quarters · filed 2026-05-04 | 259.81M shares derived: average of 4 quarters · filed 2026-05-04 | |||
| 2024-12-31 | 259.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 259.82M shares derived: average of 2 quarters · filed 2026-02-24 | 259.41M shares derived: average of 3 quarters · filed 2026-02-24 | 259.15M shares 10-K · filed 2026-02-24 | |||
| 2024-09-30 | 259.76M shares 10-Q · filed 2025-11-10 | 259.18M shares derived: average of 2 quarters · filed 2025-11-10 | 258.91M shares 10-Q · filed 2025-11-10 | 258.33M shares derived: average of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | 258.60M shares 10-Q · filed 2025-08-06 | 258.48M shares 10-Q · filed 2025-08-06 | 257.85M shares derived: average of 3 quarters · filed 2026-02-24 | 257.48M shares derived: average of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | 258.36M shares 10-Q · filed 2025-05-02 | 257.48M shares derived: average of 2 quarters · filed 2026-02-24 | 257.10M shares derived: average of 3 quarters · filed 2026-02-24 | 256.81M shares derived: average of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | 256.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 256.47M shares derived: average of 2 quarters · filed 2026-02-24 | 256.30M shares derived: average of 3 quarters · filed 2026-02-24 | 256.27M shares 10-K · filed 2026-02-24 | |||
| 2023-09-30 | 256.35M shares 10-Q · filed 2024-11-01 | 256.15M shares derived: average of 2 quarters · filed 2024-11-01 | 256.16M shares 10-Q · filed 2024-11-01 | 255.97M shares derived: average of 4 quarters · filed 2025-11-10 | |||
| 2023-06-30 | 255.95M shares 10-Q · filed 2024-08-07 | 256.06M shares 10-Q · filed 2024-08-07 | 255.84M shares derived: average of 3 quarters · filed 2025-11-10 | 255.65M shares derived: average of 4 quarters · filed 2025-11-10 | |||
| 2023-03-31 | 256.17M shares 10-Q · filed 2024-05-03 | 255.78M shares derived: average of 2 quarters · filed 2025-11-10 | 255.54M shares derived: average of 3 quarters · filed 2025-11-10 | 255.45M shares derived: average of 4 quarters · filed 2025-11-10 | |||
| 2022-12-31 | 255.39M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-10 | 255.23M shares derived: average of 2 quarters · filed 2025-11-10 | 255.21M shares derived: average of 3 quarters · filed 2025-11-10 | 255.17M shares 10-K/A · filed 2025-11-10 | |||
| 2022-09-30 | 255.07M shares 10-Q · filed 2023-11-03 | 255.11M shares derived: average of 2 quarters · filed 2023-11-03 | 255.09M shares 10-Q · filed 2023-11-03 | 255.00M shares derived: average of 4 quarters · filed 2024-02-26 | |||
| 2022-06-30 | 255.16M shares 10-Q · filed 2023-08-09 | 255.10M shares 10-Q · filed 2023-08-09 | 254.98M shares derived: average of 3 quarters · filed 2024-02-26 | 254.78M shares derived: average of 4 quarters · filed 2024-02-26 | |||
| 2022-03-31 | 255.05M shares 10-Q · filed 2023-05-05 | 254.90M shares derived: average of 2 quarters · filed 2024-02-26 | 254.65M shares derived: average of 3 quarters · filed 2024-02-26 | 254.45M shares derived: average of 4 quarters · filed 2024-02-26 | |||
| 2021-12-31 | 254.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | 254.46M shares derived: average of 2 quarters · filed 2024-02-26 | 254.25M shares derived: average of 3 quarters · filed 2024-02-26 | 254.19M shares 10-K · filed 2024-02-26 | 254.19M shares 10-K · filed 2022-03-21 | ||
| 2021-09-30 | 254.17M shares 10-Q · filed 2022-11-04 | 254.00M shares derived: average of 2 quarters · filed 2022-11-04 | 254.01M shares 10-Q · filed 2022-11-04 | 253.76M shares derived: average of 4 quarters · filed 2023-02-27 | |||
| 2021-06-30 | 253.83M shares 10-Q · filed 2022-08-05 | 253.83M shares 10-Q · filed 2021-08-16 | 253.83M shares 10-Q · filed 2022-08-05 | 253.83M shares 10-Q · filed 2021-08-16 | 253.62M shares derived: average of 3 quarters · filed 2023-02-27 | 253.59M shares derived: average of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | 253.52M shares 10-Q · filed 2022-05-06 | 253.52M shares derived: average of 2 quarters · filed 2023-02-27 | 253.52M shares derived: average of 3 quarters · filed 2023-02-27 | 253.52M shares derived: average of 4 quarters · filed 2023-02-27 | |||
| 2020-12-31 | 253.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 253.52M shares derived: average of 2 quarters · filed 2023-02-27 | 253.52M shares derived: average of 3 quarters · filed 2023-02-27 | 253.52M shares 10-K · filed 2023-02-27 | |||
| 2020-09-30 | 253.52M shares 10-Q · filed 2021-11-12 | 253.52M shares derived: average of 2 quarters · filed 2021-11-12 | 253.52M shares 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | 253.52M shares 10-Q · filed 2021-08-16 | 253.52M shares 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | 253.52M shares 10-Q · filed 2021-06-21 | ||||||
| 2019-12-31 | 253.52M shares 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |